In short. Vascular occlusion is the blockage of a blood vessel by filler, and it is one of the most serious risks of facial injection. Its signs usually appear at home within minutes to hours, so the useful preparation happens before the appointment: know what is being injected, know who to contact, and know the findings.
Key points
- Ask for the substance class and whether it can be dissolved.
- A dissolvable gel filler can be broken down with an enzyme; other classes cannot.
- Ask who answers the telephone in the evening, at the weekend or on a holiday.
- Signs usually appear away from the clinic, within minutes to hours of the injection.
- Pain out of proportion, blanching skin or any vision change means emergency care now.
Why this preparation matters
Almost everything written about vascular occlusion is written for the moment it happens. The most useful preparation happens before the injection, and it takes about a minute. It converts a patient from someone waiting to be told what is happening into the first line of recognition in an event that is usually noticed at home rather than in the clinic.
What is being injected, and can it be dissolved?
Ask for the substance class, and ask whether it can be dissolved. A dissolvable gel filler can be broken down with an enzyme; biostimulators, polycaprolactone fillers and calcium-based fillers cannot. This is not a preference about products. It is the fact that determines whether the main emergency treatment is available to you, and it is the first thing any clinician assessing a suspected occlusion will need. If you are not told, ask again, and keep the record.
Who do you contact outside clinic hours?
Ask who answers the telephone if something goes wrong in the evening, at the weekend, or on a public holiday, and what you should do if no one does. Ask, too, what the plan is if the finding involves pain out of proportion, blanching skin or a change in vision. A clear answer to that question is worth more than any assurance that complications do not happen there.
| What to settle | Why it matters | What a useful answer covers | If it is not offered |
|---|---|---|---|
| The substance class | It decides whether the main emergency treatment is available to you | The class of product being used | Ask again, and keep the record |
| Whether it can be dissolved | A dissolvable gel filler can be broken down with an enzyme; biostimulators, polycaprolactone and calcium-based fillers cannot | A plain answer for the product in front of you | Ask again, and keep the record |
| Out-of-hours contact | The signs appear away from the clinic | Who answers in the evening, at the weekend or on a public holiday | Ask what to do if no one does |
| The plan for pain, blanching or a vision change | These are the findings that need action | What the clinic would do | Treat an assurance that complications do not happen there as no plan |
| The record of treatment | A clinician assessing a suspected occlusion will need it | What was injected, where and when, with batch details if you have them | Keep your own copy |
The signs to know before you need them
Four findings are worth carrying out of the clinic. Severe pain out of proportion to the injection, or pain that keeps worsening instead of easing. Skin that turns white, grey, mottled or dusky, shows a lacy pattern, or feels cold. Any change in vision, including blurring or a curtain across the view. A drooping eyelid, or pain and swelling around the eye. Any one of them means emergency care now, and they are difficult to interpret cold, in the evening, when the finding is easy to explain away.
Why recognition falls to the patient
An occlusion is uncommon, which means most patients have never seen one and most injectors see one rarely. The signs appear away from the clinic, within minutes to hours of the injection. Nobody is better placed to notice them than the person they are happening to, and nobody else can start the clock.
What to keep at home
Keep the record of what was injected, where and when, with the batch details if you have them, and keep the clinic contact and the hospital main line somewhere you can find them without searching. Take a photograph on the day of treatment so that you have a comparison, and know that a photograph is not an assessment. None of this makes an occlusion less likely. It makes it more likely to be recognised in the minutes that decide what follows.
When is it an emergency?
Pain that is severe, out of proportion to the injection or worsening rather than easing is an emergency. So is skin that turns white, grey, mottled or dusky, shows a lacy pattern or feels cold, and any change in vision, a drooping eyelid, or pain and swelling around the eye. Seek emergency care now rather than waiting for a routine appointment. This site is patient education and cannot assess you; what it can do is make the findings familiar enough that they are acted on rather than explained away.
Sources
- NICE: interventional procedures guidance on dermal fillers for facial aesthetics
- Medicines and Healthcare products Regulatory Agency: safety information on dermal fillers
- American Society for Dermatologic Surgery: patient information on filler complications and vascular occlusion
Internal links
Frequently asked questions
What should I ask before a filler injection?
Which substance class is being used, whether it can be dissolved if something goes wrong, who to contact outside clinic hours, and what the plan is if you develop pain out of proportion, blanching skin or a change in vision. Those four answers take a minute to obtain and they are the difference between recognising an event and wondering about one.
Should I be told the risks before treatment?
Yes. Vascular occlusion is uncommon but it is the most serious risk of facial filler, and a patient who is not told about it cannot recognise it. Consent that does not mention it is not consent to it. You are entitled to ask what happens if it occurs and who will be available.
Does knowing the signs make any real difference?
It does, because the signs appear at home rather than in the clinic, usually within minutes to hours of the injection, and the person present is the patient. Recognition is the part of this event that patients control, and it is the part that decides how much time passes before treatment starts.
Risks & Limitations
- The site of the injection is not the site of the damage: filler that enters an artery is carried by the blood flow and lodges downstream.
- Only a filler of the enzyme-dissolvable class can be dissolved. Biostimulators, polycaprolactone and calcium-based fillers cannot.
- Dissolving the product removes the cause; it does not repair tissue that has already lost its blood supply.
- The glabella, nose, forehead, temple and tear trough share a blood supply with the eye, which is why they are treated with particular care.
- A change in vision after a facial injection is an emergency in which minutes matter, and recovery cannot be assumed.
- Where skin or vision has been lost, later treatment can improve an area but does not restore what was there before.
When to Seek Care
- Severe pain out of proportion to the injection, or pain that keeps worsening — seek emergency care now.
- Skin turning white, grey, mottled or dusky, a lacy or blotchy pattern, or skin that feels cold — seek emergency care now.
- Any change in vision, a drooping eyelid, or pain and swelling around the eye — seek emergency care now; minutes matter.
- Blistering, peeling or darkening skin over a treated area — seek emergency care now.
- A severe headache, or weakness or numbness on one side of the body — seek emergency care now and call emergency services.
- A reaction that is not settling but is not in this list — contact your treating team the same day.
References & Further Reading
- American Society of Plastic Surgeons (ASPS) — injectable filler safety guidance
- U.S. Food and Drug Administration (FDA) — dermal filler safety information
- National Institute for Health and Care Excellence (NICE, UK) — relevant guidance
- Cochrane Library — systematic reviews
- Chinese Medical Association Plastic Surgery Branch — clinical guidance
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.